AFFERENT TECHNOLOGIES SL

Their core work

Afferent Technologies is a Barcelona-based medtech SME building intelligent safety systems for surgical environments. Their work spans two tightly connected domains: wireless intraoperative nerve monitoring (detecting and preventing accidental nerve damage during surgery) and AI-driven detection of human behavioral errors in the operating room. Both projects address the same underlying problem — preventable harm in surgery caused by inadequate real-time feedback to surgical teams. The company operates at the intersection of medical hardware, wireless sensing, and applied machine learning.

What they specialise in

How they've shifted over time

In 2017, Afferent's focus was hardware-oriented: a wireless sensor system for nerve monitoring, a physical device solving a real-time intraoperative problem. By 2019, they had shifted toward software and AI, applying machine learning to model and reduce human behavioural errors in surgery. This is a clear and deliberate pivot from sensing hardware to intelligent decision-support — a trajectory that tracks closely with the broader medtech industry move toward AI-augmented surgery between 2017 and 2020.

Afferent is moving from physical sensor products toward AI software layers for operating room safety, suggesting future collaboration opportunities in surgical AI, human factors engineering, and digital surgery platforms.

How they like to work

Afferent has led both of its H2020 projects as coordinator, indicating comfort with EU project management and a preference for driving their own research agenda rather than slotting into larger consortia. With only one unique partner across two projects, they operate in very tight, focused teams — this is a company that prefers deep bilateral collaboration over broad multi-partner networks. Partnering with them likely means close working relationships, but limited consortium-building capacity on their side.

Afferent's H2020 network is minimal: one unique partner across two projects, all within Spain. This suggests they are still in early network-building phase and have not yet established multi-country research connections.

What sets them apart

Afferent occupies a narrow but commercially valuable niche: surgical safety technology that bridges hardware sensing and AI inference, both aimed at preventing intraoperative harm. Very few SMEs have pursued both physical nerve monitoring and AI behavioural analysis within the same operating-room safety theme. For consortium builders in digital surgery, surgical robotics, or AI-in-healthcare projects, they bring a focused clinical problem statement backed by at least two completed EU feasibility validations.

Highlights from their portfolio

• WiNerve
  First project establishing the company's core clinical problem — wireless real-time nerve protection during surgery — and validated as commercially viable under the competitive SME Instrument Phase 1.
• BESAFE
  Marks a significant technological pivot toward AI, applying machine learning to human behavioural error reduction in surgery — an unusual and commercially relevant combination at the time of funding (2019).